跳至主要内容
临床试验/NCT02652143
NCT02652143终止不适用

Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy? A Sibling Oocyte, Prospective, Multi-centric, Randomized, Open Study, Clinical Study in Subjects With Subfertility Undergoing Assisted Reproductive Medical Treatment

Anecova SA1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
35
试验地点
1
主要终点
Euploidy status after a biopsy on all viable day 5 embryos

研究概览

简要总结

This Clinical Study has been designed to assess and compare the impact of in vitro or in vivo culture conditions on the euploidy of sibling blastocysts.

详细描述

As soon as the very first minute of the fertilization process, very important biological events, critical for the future developmental competency of the embryo are taking place.

These biological events, after the sperm cell entry in the oocyte cytoplasm and prior to the first cleavage, include: the completion of the meiosis, the exclusion of the second polar body, the pronuclei formation, the replication of the male and female DNA and the chromosome segregation on the newly formed mitotic spindle.

If any of these events is aberrant, one or both of the two daughter cells and their descendants may carry chromosomal anomalies. In other words an uneven first cleavage in size or in content is associated with chromosomal abnormality and aneuploidy.

In vivo all these events occur in a natural environment where the presence of specific molecules and of a dynamic and physiological environment might be an advantage over in vitro culture conditions to ensure optimal cellular functions.

Preliminary data from the pilot study have shown a higher proportion of euploid embryos for sibling oocytes cultured in vivo vs. in vitro. Moreover, in animal models, in vivo cultured embryos have been described with significant reduction of aneuploidies and with differences in the gene expression levels patterns when compared to in vitro cultured embryos. There is also growing evidence that the culture conditions of human pre-implantation embryos can affect the gene expression regulation with measurable effects on embryos and on newborn children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Signed Informed Consent by the subject and her partner
  • Women, aged between 18 and 38 years (up to 38th birthday)
  • ≤ 2 previous stimulation cycles
  • Routinely measured hormonal levels within normal range (i.e. FSH, LH, E2, PRL)
  • No uterine or ovarian anatomical abnormalities and/or alterations that would compromise device delivery or function in the uterus as demonstrated by ultrasound and trial insertion
  • 19 ≤ BMI ≤ 29 kg/m2

排除标准

  • History of previous moderate or severe ovarian hyperstimulation syndrome (OHSS)
  • Severe endometriosis
  • Any active infection that would contraindicate ART, at the discretion of the investigator
  • Severe male factor in the partner (cryptozoospermia or non-obstructive azoospermia)

研究组 & 干预措施

sibling oocytes in vivo

Experimental

randomized oocytes assigned to in vivo culture

干预措施: AneVivo (Medical device for in vivo culture of embryos) (Device)

sibling oocyte in vitro

Active Comparator

randomized oocytes assigned to in vitro culture

干预措施: comparator for embryo culture in vitro (Other)

结局指标

主要结局

Euploidy status after a biopsy on all viable day 5 embryos

时间窗: 1 week

full genome analysis on 24 chromosomes

次要结局

  • Implantation rate(9 weeks)
  • Pregnancy rate(9 weeks)

研究者

发起方
Anecova SA
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验